Paul Tudor Jones's AMGN Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 825 shares of Amgen Inc. (AMGN) worth $347,746, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2024, adding 164,400 shares. Largest reduction occurred in Q2 2024, reducing 164,400 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +825 | New Buy | 825 | $421.51 |
| Q4 2025 | -119,834 | Sold Out | 0 | $0.00 |
| Q3 2025 | +62,743 | Add 109.90% | 119,834 | $282.20 |
| Q2 2025 | +6,736 | Add 13.38% | 57,091 | $279.21 |
| Q1 2025 | -8,814 | Reduce 14.90% | 50,355 | $311.55 |
| Q4 2024 | +59,169 | New Buy | 59,169 | $260.64 |
| Q2 2024 | -164,400 | Sold Out | 0 | $0.00 |
| Q1 2024 | +164,400 | New Buy | 164,400 | $284.32 |
| Q3 2023 | -18,616 | Sold Out | 0 | $0.00 |
| Q2 2023 | -78,777 | Reduce 80.89% | 18,616 | $222.02 |
| Q1 2023 | +97,393 | New Buy | 97,393 | $0.24 |
| Q3 2022 | -11,779 | Sold Out | 0 | $0.00 |
| Q2 2022 | +7,160 | Add 155.01% | 11,779 | $243.31 |
| Q1 2022 | +4,619 | New Buy | 4,619 | $241.83 |
| Q4 2021 | -4,491 | Sold Out | 0 | $0.00 |
| Q3 2021 | -1,371 | Reduce 23.39% | 4,491 | $212.65 |
| Q2 2021 | +5,862 | New Buy | 5,862 | $243.77 |
| Q3 2020 | -7,423 | Sold Out | 0 | $0.00 |
| Q2 2020 | -3,364 | Reduce 31.19% | 7,423 | $235.89 |
| Q1 2020 | -507 | Reduce 4.49% | 10,787 | $202.74 |
| Q4 2019 | +11,294 | New Buy | 11,294 | $241.10 |
| Q3 2019 | -2,279 | Sold Out | 0 | $0.00 |
| Q2 2019 | -36,014 | Reduce 94.05% | 2,279 | $184.29 |
| Q1 2019 | +38,293 | New Buy | 38,293 | $189.98 |
| Q3 2018 | -16,497 | Sold Out | 0 | $0.00 |
| Q2 2018 | -8,757 | Reduce 34.68% | 16,497 | $184.58 |
| Q1 2018 | +15,538 | Add 159.92% | 25,254 | $170.47 |
| Q4 2017 | +9,716 | New Buy | 9,716 | $173.94 |
| Q2 2017 | -7,832 | Sold Out | 0 | $0.00 |
| Q1 2017 | +4,132 | Add 111.68% | 7,832 | $164.07 |
| Q4 2016 | -17,633 | Reduce 82.66% | 3,700 | $146.22 |
| Q3 2016 | +15,664 | Add 276.31% | 21,333 | $166.83 |
| Q2 2016 | +369 | Add 6.96% | 5,669 | $152.23 |
| Q1 2016 | -2,729 | Reduce 33.99% | 5,300 | $150.00 |
| Q4 2015 | +1,229 | Add 18.07% | 8,029 | $162.29 |
| Q3 2015 | -1,175 | Reduce 14.73% | 6,800 | $138.38 |
| Q2 2015 | -1,890 | Reduce 19.16% | 7,975 | $153.48 |
| Q1 2015 | +5,265 | Add 114.46% | 9,865 | $159.86 |
| Q4 2014 | +1,300 | Add 39.39% | 4,600 | $159.35 |
| Q3 2014 | -5,713 | Reduce 63.39% | 3,300 | $140.61 |
| Q2 2014 | +5,028 | Add 126.17% | 9,013 | $118.38 |
| Q1 2014 | -3,712 | Reduce 48.23% | 3,985 | $123.46 |
| Q4 2013 | +7,697 | New Buy | 7,697 | $114.07 |
| Q3 2013 | -6,300 | Sold Out | 0 | $0.00 |
| Q2 2013 | +6,300 | Add 0.00% | 6,300 | $98.73 |
Paul Tudor Jones's Amgen Investment FAQs
Paul Tudor Jones first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 6,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Amgen Inc. (AMGN) for 45 quarters since Q2 2013.
Paul Tudor Jones's largest addition to Amgen Inc. (AMGN) was in Q1 2024, adding 164,400 shares worth $46.74 M.
According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 825 shares of Amgen Inc. (AMGN), valued at approximately $347,746.
As of the Q3 2026 filing, Amgen Inc. (AMGN) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Amgen Inc. (AMGN) was 164,400 shares, as reported at the end of Q1 2024.